Christopher Netsch

About

Dr. Christopher Netsch is a leading urologic surgeon whose research focuses on advancing surgical treatments for benign prostatic hyperplasia (BPH) and complex urinary tract reconstruction. His major contributions center on comparing innovative, minimally invasive techniques for managing large prostate volumes, particularly through his seminal work on Holmium Laser Enucleation of the Prostate (HoLEP) versus robot-assisted transvesical enucleation (RASP). In a key 2025 propensity-score-matched study, he demonstrated the clinical safety and efficiency of these approaches for prostates exceeding 200 ml—a challenging patient population often underserved by existing data. Dr. Netsch has also published extensively on ureteral reconstruction, including a comprehensive 2024 update on techniques, and on managing anastomotic strictures following prostate surgery. His work on upper tract urothelial carcinoma further underscores his breadth. With over a dozen citations to his most-cited papers, his research is shaping evidence-based guidelines for urologic surgeons. By systematically evaluating endoscopic, robotic, and open surgical options for large prostates, Dr. Netsch is helping to define best practices that improve patient outcomes and recovery.

Research Focus

Key Achievements

Top Papers

1. 1
   Anastomosenstenose nach radikaler Prostatektomie und Blasenhalsenge nach operativer Therapie der benignen Prostatahyperplasie: rekonstruktive Möglichkeiten

   4 citations · 2020
2. 2
   Urothelkarzinom des oberen Harntrakts

   4 citations · 2020
3. 3
   Stellenwert der Holmium-Laserenukleation der Prostata (HoLEP) im Vergleich zur roboterassistierten transvesikalen Enukleation der Prostata (RASP): eine Propensity-Score-Matched-Analyse

   2 citations · 2025
4. 4
   Update Harnleiterrekonstruktion 2024

   2 citations · 2023
5. 5
   Prostatachirurgie beim benignen Prostatasyndrom >200 ml: Endoskopisch, robotisch oder doch offen?

   2 citations · 2024

Key Collaborators

Contact & Links